The relationship between CD5-expressing B lymphocytes and serologic abnormalities in rheumatoid arthritis patients and their relatives

Arthritis Rheum. 1990 Mar;33(3):339-48. doi: 10.1002/art.1780330306.

Abstract

The influence of genetic factors on the expression of CD5+ B lymphocytes and their relationship to a broad spectrum of autoantibodies was investigated in a study of 12 patients with rheumatoid arthritis (RA) and 52 of their healthy first-degree relatives. The proportion of CD5+ B cells was significantly higher in RA patients (mean +/- SEM 23.9 +/- 2.7%) compared with that in their relatives (18.3 +/- 1.1%, P less than 0.05) and compared with that in a group of healthy control subjects (16.1 +/- 1.8%; P less than 0.05). Much more striking, however, were the high levels of CD5+ B cells found in the patients and their relatives in 5 of the families studied. Increases in total immunoglobulin levels and autoantibody levels were frequently observed in RA patients (approximately 20-40%) and their relatives (approximately 10-20%). Furthermore, a statistically significant correlation (P less than 0.01) between IgM rheumatoid factor and the percentage of B lymphocytes expressing CD5 was observed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antigens, Differentiation / genetics*
  • Antigens, Differentiation / immunology
  • Arthritis, Rheumatoid / diagnosis
  • Arthritis, Rheumatoid / genetics
  • Arthritis, Rheumatoid / immunology*
  • B-Lymphocytes / immunology*
  • CD5 Antigens
  • Female
  • Humans
  • Immunoglobulin A / analysis
  • Immunoglobulin G / analysis
  • Immunoglobulin M / analysis
  • Male
  • Middle Aged
  • Pedigree
  • Rheumatoid Factor / analysis
  • Serologic Tests

Substances

  • Antigens, Differentiation
  • CD5 Antigens
  • Immunoglobulin A
  • Immunoglobulin G
  • Immunoglobulin M
  • Rheumatoid Factor